Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Cytotoxicity of different extracts of Mucuna pruriens seeds on hepatoma cells but not on normal hepatic cells

    wadmin2By wadmin2December 12, 2014Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Rajnish Kumar Yadava, Mahendra Singha, Srimanta Sarkarb, Siddhartha Maityc and Sudipta Sahaa*
    aDepartment of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226025, India.
    bDepartment of Pharmacy, National University of Singapore, 18, Science Drive 4, Singapore 117543.
    cDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.

    Pharmacognosy Communications,2015,5,1,63-69.
    DOI:10.5530/pc.2015.1.6
    Published:12 2014
    Type:Research Article

    ABSTRACT

    Object: Cancer has become leading cause of death in India as well as world. Synthetic anticancer agents have costly and highly toxic to human body. Therefore, it is necessary to discover new therapeutic agents from natural origin for this disease. Materials and Methods: Mucuna pruriens Linn. (MP) (family Fabaceae), is widely used in folk medicine and there is no any such report on antiproliferative effects of this plant. The first objective of this study is to investigate the anticancer properties using hepatoma cells of MP seeds. The first objective of this study is to investigate the anticancer properties of MP seeds by using/on hepatoma cells. Secondly, it is necessary to explore its hepatotoxicity potential in normal cells as well. Therefore, the other objective of this study is to investigate the toxicity using normal hepatic cells. To achieve this goal, hot extraction of MP seeds were performed using petroleum ether 60-80°C (PE), ethyl acetate (EA) and Methanol (ME) as a solvent. All the three extracts were subjected to screen for anti-proliferative action using human hepatoma cell line (Huh-7 cells) at different concentrations from 0.5 to 100 μg/ml, followed by apoptotic activity using caspase-3 enzymes. On the other hand, hepatoprotective activity was performed using human primary hepatic cells (THLE-2 cells). Results: Our result collectively suggested that both EA and ME extract possessed anti-proliferative action on Huh-7 cells and less cytotoxic action on normal cells. Conclusion: Among these two extracts, it is demonstrated for the first time that ME extracts of MP seeds have cytotoxic effect on hepatoma cells but not on normal hepatic cells.

    Keywords: Mucuna pruriens seeds, Huh-7 cells, THLE-2 cells, anti-proliferation action, hepatoprotective action.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up